Imetelstat, sold under the brand name Rytelo, is an anti-cancer medication used for the treatment of myelodysplastic syndromes with transfusion-dependent...
15 KB (723 words) - 17:41, 15 August 2024
sponsored human clinical trials of several potential anti-cancer products. Imetelstat (GRN163L) is a drug that targets telomerase. In studies conducted at Johns...
23 KB (2,160 words) - 03:10, 15 August 2024
Enasidenib Epacadostat Eribulin Estramustine Glasdegib Idecabtagene vicleucel Imetelstat Ivosidenib Lifileucel Lonidamine Lucanthone Lurbinectedin Mitoguazone...
11 KB (729 words) - 05:53, 22 August 2024
Enasidenib Epacadostat Eribulin Estramustine Glasdegib Idecabtagene vicleucel Imetelstat Ivosidenib Lifileucel Lonidamine Lucanthone Lurbinectedin Mitoguazone...
31 KB (2,906 words) - 07:45, 19 August 2024
Enasidenib Epacadostat Eribulin Estramustine Glasdegib Idecabtagene vicleucel Imetelstat Ivosidenib Lifileucel Lonidamine Lucanthone Lurbinectedin Mitoguazone...
36 KB (3,299 words) - 19:46, 10 August 2024
Enasidenib Epacadostat Eribulin Estramustine Glasdegib Idecabtagene vicleucel Imetelstat Ivosidenib Lifileucel Lonidamine Lucanthone Lurbinectedin Mitoguazone...
61 KB (6,082 words) - 05:23, 17 June 2024
Enasidenib Epacadostat Eribulin Estramustine Glasdegib Idecabtagene vicleucel Imetelstat Ivosidenib Lifileucel Lonidamine Lucanthone Lurbinectedin Mitoguazone...
20 KB (1,809 words) - 03:48, 24 July 2024
Enasidenib Epacadostat Eribulin Estramustine Glasdegib Idecabtagene vicleucel Imetelstat Ivosidenib Lifileucel Lonidamine Lucanthone Lurbinectedin Mitoguazone...
14 KB (1,105 words) - 05:16, 2 July 2024
Enasidenib Epacadostat Eribulin Estramustine Glasdegib Idecabtagene vicleucel Imetelstat Ivosidenib Lifileucel Lonidamine Lucanthone Lurbinectedin Mitoguazone...
18 KB (1,467 words) - 23:44, 20 August 2024
been tested in mouse models, and clinical trials have begun. One drug, imetelstat, is being clinically researched as a means of interfering with telomerase...
49 KB (5,644 words) - 06:05, 27 April 2024